- Home
- CLNN vs ELEV Comparison
CLNN vs ELEV Comparison
Compare CLNN & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- ELEV
- Stock Information
- Founded
- CLNN 2012
- ELEV 2019
- Country
- CLNN United States
- ELEV United States
- Employees
- CLNN N/A
- ELEV N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- CLNN Health Care
- ELEV Health Care
- Exchange
- CLNN Nasdaq
- ELEV Nasdaq
- Market Cap
- CLNN 35.9M
- ELEV N/A
- IPO Year
- CLNN N/A
- ELEV 2021
- Fundamental
- Price
- CLNN $2.57
- ELEV $0.25
- Analyst Decision
- CLNN Strong Buy
- ELEV Buy
- Analyst Count
- CLNN 4
- ELEV 7
- Target Price
- CLNN $55.25
- ELEV $3.78
- AVG Volume (30 Days)
- CLNN 53.5K
- ELEV 2.1M
- Earning Date
- CLNN 05-07-2025
- ELEV 03-06-2025
- Dividend Yield
- CLNN N/A
- ELEV N/A
- EPS Growth
- CLNN N/A
- ELEV N/A
- EPS
- CLNN N/A
- ELEV N/A
- Revenue
- CLNN $342,000.00
- ELEV N/A
- Revenue This Year
- CLNN N/A
- ELEV N/A
- Revenue Next Year
- CLNN $17,399.78
- ELEV N/A
- P/E Ratio
- CLNN N/A
- ELEV N/A
- Revenue Growth
- CLNN N/A
- ELEV N/A
- 52 Week Low
- CLNN $2.57
- ELEV $0.24
- 52 Week High
- CLNN $9.20
- ELEV $5.83
- Technical
- Relative Strength Index (RSI)
- CLNN 19.09
- ELEV 22.73
- Support Level
- CLNN $3.09
- ELEV $0.24
- Resistance Level
- CLNN $4.66
- ELEV $0.27
- Average True Range (ATR)
- CLNN 0.31
- ELEV 0.04
- MACD
- CLNN -0.16
- ELEV -0.01
- Stochastic Oscillator
- CLNN 0.00
- ELEV 2.13
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).